CTOs on the Move

CardiaLen

www.cardialen.com

 
Established in 2008, Cardialen, Inc., set out to develop an implantable defibrillator using low-electrical energy to restore normal heart rhythm and potentially avoid the negative side-effects of current therapies.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.cardialen.com
  • 212 Third Ave. N. Suite 352
    Minneapolis, MN USA 55401
  • Phone: 612.208.1260

Executives

Name Title Contact Details

Funding

CardiaLen raised $17M on 10/10/2018

Similar Companies

Adrian Elwell at Au Top

Adrian Elwell at Au Top is a Danville, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

EMD Biosciences

EMD Biosciences, Inc. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Primmune Therapeutics

Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Our goal is to improve the response rate of patients to current and future immunotherapy medicines.

NICO

NICO gives hope to patients with primary and secondary brain tumors, cysts and hemorrhagic strokes.

Adcentrx Therapeutics

Adcentrx Therapeutics is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases.